Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL 1 null mutant vector - Potential glioblastoma targeting

Gene Therapy

Volumn 5, Issue 4, 1998, Pages 440-450

  McKie, E A ^a,b   Graham, D I ^b   Brown, S M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

GFAP promoter; Glioma therapy; HSV 1; RL1 variants

Indexed keywords

BETA GALACTOSIDASE; GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; FEMALE; GENE EXPRESSION; GENE TARGETING; GLIOBLASTOMA; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; TRANSGENE;

ANIMALIA; ESCHERICHIA COLI; HUMAN HERPESVIRUS 1;

EID: 0031917022     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300621     Document Type: Article

References (32)

1. Roizman B. The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors. Proc Natl Acad Sci USA 1996, 93: 11307-11312.
2. Glorioso JC et al. HSV as a gene transfer vector for the nervous system. Mol Biotechnol 1995; 4. 87-99.
3. Andreansky SS et al. The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumours. Proc Natl Acad Sci USA 1996; 93: 11313-11318.
4. Brown SM et al. Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5 negative herpes simplex virus. J Gen Virol 1994; 75: 2367-2377.
5. Brown SM, MacLean AR, Aitken JD, Harland J. ICP34.5 influences herpes simplex virus type 1 maturation and egress from infected cells in vitro. J Gen Virol 1994; 75: 3679-3686.
6. Chou J, Roizman B. The 34.5 gene of herpes simplex virus type 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programmed cell death in neuronal cells. Proc Natl Acad Sci USA 1992; 89: 3266-3270.
7. Chou J, Chen J-J, Gross M, Roizman B. Association of a Mr 90 000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2α and premature shut-off of protein synthesis after infection with γ34.5- mutants of herpes simplex virus 1. Proc Natl Acad Sci USA 1995; 92: 10516-10520.
8. Thompson RL, Stevens JG. Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent. Virology 1983; 131: 171-179.
9. Chou J, Roizman B. The herpes simplex virus type 1 gene for ICP34.5 which maps in inverted repeats is conserved in several limited passage strains but not in strain 17 syn+. J Virol 1990; 64: 1014-1020.
10. MacLean AR et al Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence related sequences in Glasgow strain 17+ between immediate-early gene 1 and the 'a' sequence. J Gen Virol 1991; 72: 631-639.
11. McKie EA, Hope RG, Brown SM, MacLean AR. Characterization of the herpes simplex virus type 1 strain 17+ neurovirulence gene RL1 and its expression in a bacterial system. J Gen Virol 1994; 75: 733-741.
12. Robertson LM, MacLean AR, Brown SM. Peripheral replication kinetics and latency reactivation kinetics of the non-neurovirulent herpes simplex virus type 1 variant 1716. J Gen Virol 1992; 73: 967-970.
13. Whitley RJ et al. Replication, establishment of latency, and induced reactivation of herpes simplex virus γ134,5 deletion mutants in rodent models. J Clin Invest 1993; 91: 2837-2843.
14. Valyi-Nagy T et al. The HSV-1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice. J Gen Virol 1994; 75: 2059-2063.
15. Markert JM, Malick A, Coen DM, Martuza RL. Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex virus mutants that retain susceptibility to acyclovir. Neurosurgery 1993; 32: 597-603.
16. Chambers RJ et al. Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumours in a SCID mouse model of human malignant glioma. Proc Natl Acad Sci USA 1995; 92: 1411-1415.
17. Randazzo RBP et al. Treatment of experimental intracranial murine melanoma with neuroattenuated herpes simplex virus type 1 mutant. Virology 1995; 211: 94-101.
18. Brenner M et al. GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci 1994; 14: 1030-1037.
19. Nakatani Y et al. A downstream initiation element required for efficient TATA box binding and in vitro function of TFIID. Nature 1990; 348: 86-88.
20. Besnard F et al. Multiple interacting sites regulate astrocyte-specific transcription of the human gene for glial fibrillary acidic protein. J Biol Chem 1991; 266: 18877-18883.
21. Ward PL, Barker DE, Roizman B. A novel herpes simplex virus 1 gene UL43.5 maps antisense to the UL43 gene and encodes a protein which co-localizes in nuclear structures with capsid proteins. J Virol 1996; 70: 2684-2690.
22. McKie EA et al. Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 mutants in primary human CNS tumours - evaluation of a potentially effective clinical therapy. Br J Cancer 1996; 74. 745-752.
23. Coffin RS, MacLean AR, Latchman DS, Brown SM. Gene delivery to the central and peripheral nervous system of mice using HSV1 ICP34.5 deletion mutant vectors. Gene Therapy 1996, 3: 886-891.
24. Kesari S et al. Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant. Lab Invest 1995; 73: 636-648.
25. Mineta T et al. Attenuated multi-mutated herpes-simplex virus-1 for the treatment of malignant gliomas. Nature Med 1995; 1: 938-943
26. Kesari S et al. Selective vulnerability of mouse CNS neurons to latent infection with a neuroattenuated herpes simplex virus-1. J Neurosci 1996; 16: 5644-5653.
27. Bovolenta P, Liem RKH, Mason CA. Development of cerebellar astroglia: transitions in form and cytoskeletal content. Dev Biol 1984; 102: 248-259.
28. MacPherson I, Stoker MG. Polyoma transformation of hamster cell clones an investigation of the genetic factors affecting cell competence. Virology 1962; 16: 147-151.
29. Kennedy PGE, Clements GB, Brown SM. Herpes simplex virus (HSV) infection of cultured foetal cells of neurological origin. Brain 1983; 106: 101-119.
30. Brown SM, Ritchie DA, Subak-Sharpe JH. Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map. J Gen Virol 1973; 18: 329-346.
31. MacLean CA et al. Investigation of herpes simplex virus type 1 genes encoding multiply inserted membrane proteins. J Gen Virol 1991; 72: 897-906
32. Manniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1982.